Nivagen Pharmaceuticals, Inc.
Andrea Felix is an experienced professional in the pharmaceutical industry, currently serving as the National Account Director at Nivagen Pharmaceuticals, Inc. since February 2019. Previously, Andrea held the same title at Perrigo Company plc from April 2007 to April 2018, overseeing the generic portfolio with significant accounts such as ClarusOne and McKesson. Prior to that, Andrea worked as a National Account Executive at Fougera Pharmaceuticals Inc. from 1994 to 2007, managing key national accounts, and started a career in healthcare as a Registered Nurse at UCLA Health from 1992 to 1995. Education was completed at Santa Monica College.
This person is not in any offices
Nivagen Pharmaceuticals, Inc.
Nivagen is engaged in the development, acquisition, and sales of generic prescription drugs and over the counter products for the North American market. It envisions to deliver high-quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.The US genericprescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in the next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, they can provide cost savings to the consumer while creating value for all members of the supply chain.